IISc-Bengaluru's 'warm' COVID vaccine powerful against all significant variants of concern: Study
Date: 16 Jul,2021 A heat-tolerant COVID-19 vaccine formulation developed by the Indian Institute of Science (IISc) Bengaluru has proven effective against all current SARS-CoV-2 variants of concern, according to a study in animals. The research, published in the ACS Infectious Diseases journal on Thursday, showed the vaccine formulations by IISc-incubated biotech start-up Mynvax triggered a strong immune response in mice. The formulation also protected hamsters from the virus and remained stable at 37 degrees Celsius up to a month, and at 100 degrees Celsius for up to 90 minutes, the research...